The heads of RBMA and three other medical management associations are locking arms and pointing their voices in the general direction of Washington.

Backed with financial support and technical prowess from the U.S. Department of Energy, NorthStar Medical Radioisotopes has shown it can produce, at scale, a critical nuclear imaging radiotracer without using highly enriched uranium.

Healthcare stakeholders throughout U.S. medicine, including radiology leaders, aren’t waiting for the ink to dry before speaking their minds.

A molecular contrast agent previously cleared for use during surgery for ovarian cancer may now be used in similar fashion during lung operations.

Mahadevappa Mahesh, PhD, professor of radiology and a medical physicist at the Johns Hopkins University School of Medicine, explains a new ACR effort to ensure that lower radiation dose X-ray images under Image Wisely and As Low as Reasonable Achievable (ALARA) meet diagnostic reading standards.

The Dallas-based company says its product incorporates bias-busting algorithms that overcome the lack of diverse populations available for model training.

The gain came with the delayed discovery of only a few clinically significant cancers.

Women with dense breasts or other heightened risk factors for breast cancer may be on the cusp of receiving 100% coverage for additional imaging beyond standard mammography.